Under normal conditions a possible N-nitrosodimethylamine formation in vivo cannot directly be monitored in urine due to high metabolic conversion rate (>99.9%). Own experiments showed an increased excretion rate (up to 2.4%) if ethanol was administered simultaneously. This model was used for monitoring experiments with repect to in vivo formation of N-nitrosodimethylamine. Amidopyrine, as a compound which is easily nitrosated, was administered (single oral dose of 500 mg) to volunteers. Under the influence of 20-30 g ethanol it was possible to detect N-nitrosodimethylamine in urine. From negative control experiments it must be concluded that this appearance of N-nitrosodimethylamine derives from in vivo nitrosation of the drug. The amount excreted in urine varied between 0.5 and 10 jtg Nnitrosodimethylamine within 8 h and seemed to be influenced by salivary nitrite concentrations which ranged from 5 to 220 p.p.m. NO2.In comparison with earlier excretion studies in humans it can be assumed that only 1-2% of the originally formed nitrosamine was found in urine. To our knowledge this is the first time that in vivo formation of Nnitrosodimethylamine was directly shown to occur in humans.
Introduction
Certain drugs containing secondary or tertiary amino groups can react with nitrite in an acidic medium to form N-nitroso compounds. Several investigations have demonstrated the outstanding reactivity of the analgesic, antipyretic drug aminopyrine (AP)* towards nitrosating agents (1-3).
Among the main nitrosation products, the formation of the potent carcinogen N-nitrosodimethylamine (NDMA) is of specific relevance. In rat feeding experiments with AP together with nitrite Lijinsky et al. (4) observed malignant tumors of liver and lung due to endogenously formed NDMA. It was concluded, therefore, that the use of AP presents a potential carcinogenic hazard to man (4) . It is very likely that in vivo nitrosation of AP occurs in humans, (i) The necessary nitrosating agent, nitrite, is a normal consitutent of human saliva (5, 6) . (ii) The acidic environment of the stomach favours the nitrosation reaction, (iii) The intake of AP is followed by continuous excretion via salivary glands as long as appreciable amounts of the drug are present in the blood (7) . Therefore a continuous formation of NDMA can occur up to 6 h after a single dose of AP. It was not possible, however, to demonstrate whether and to what extent an endogenous nitrosation of AP takes place in humans. Monitoring of the formed NDMA in urine seemed not to be possible due to
•Abbreviations: NDMA, N-nitrosodimethylamine; AP, amidopyrine (aminophenazone) its high metabolic conversion rate which is >99.9% (8) .
Further studies however, showed that excretion rates of ingested NDMA are increased by simultaneous consumption of small amounts of ethanol (8) . The observed elevated excretion rates of orally administered NDMA were as high as 2.4%. This phenomenon is obviously related to an inhibition of NDMAmetabolism by ethanol in the liver (9 -12) .
With the available analytical methods (detection limit of 0.05 /tg/1 NDMA) it should now be possible to monitor even low NDMA exposures (10-100 jtg NDMA) in humans. We therefore proposed to use this ethanol effect as a suitable tool to estimate the extent of the NDMA-wz vivo formation in humans.
The following results demonstrate the use of the 'ethanol effect' for biological monitoring of in vivo formation of NDMA after amidopyrine intake.
Materials and methods

Chemicals
Amidopyrine was purchased from Merck (Darmstadt, FRG) and checked for NDMA contamination. The NDMA content was <20 /ig/kg. Other chemicals and solvents (Merck, Darmstadt, FRG) were of analytical grade or were purified prior to usage.
Food analysis
Mineral water, beer and radish used in this study were analysed for nitrate content. Mineral water and beer contained < 10 p.p.m. nitrate, the nitrate content of radish was 800-1200 p.p.m.
Beer was also analysed for NDMA and did not contain volatile N-nitrosamines
Experimental design
Three volunteers (A, B, C) participated in this study. In all experiments a continental breakfast was taken 1 -2 h before beginning the experiment. Urine and saliva samples were taken 1 h before, at the start of the experiment and every hour afterwards for up to 6 h. At the start (8.30 a.m.) volunteers received beverages (beer with an ethanol content of 40 g/1 or mineral water) and/or a nitrate-rich vegetable (radish, 250 g containing 200-300 mg nitrate), followed 1 h later by intake of 500 mg AP and then a beverage (beer or mineral water) between 12.00 and 14.00 hours according to the following protocols:
(1) 250 g radish + 500 ml beer; 500 mg AP; 500 ml beer (2) 500 ml beer; 500 mg AP; 500 ml beer (no nitrate) (3) 250 g radish + 500 ml mineral water; 500 mg AP; 500 ml mineral water (no ethanol) (4) 250 g radish + 500 ml beer; 500 ml beer (no AP).
The volunteers A and C followed protocols 1 -4; volunteer B followed protocols 1-3. They were allowed to take non-alcoholic drinks and a meal during the experiment but asked to avoid nitrate-rich items. Urine and saliva samples were made alkaline immediately after collection.
Nitrite-nitrate measurements
Nitrite and nitrate concentrations were determined in urine, saliva and vegetable samples using a dual channel continuous flow analyser (Skalar analytical instruments, Breda, The Netherlands) equipped with an automatic sampler, a multichannel peristaltic pump for sample and reagent delivery and a reducing column for nitrate to nitrite conversion.
Principle of the method: nitrite was determined by diazotising with sulfanilamide and coupling with N-(l-naphthyl)ethylenediamine to form coloured azo dye which is measured at 540 nm in a 10 mm flow cell. Sensitivity range was 1-50 p.p.m. NO? Nitrate was determined after reduction in an on-line column containing granulated copper cadmium as nitrite together with the originally present nitrite. The nitrate content was then calculated by subtraction. Sensitivity range was 2 -250 p.p.m. Higher concentrations were determined after dilution.
N-Nitrosamine measurements
NDMA concentrations in urine were determined after direct extraction with dichloromethane using Kieselguhr columns (13) and measurement of the concentrated extracts by gas chromatography (HP 5880, Hewlett Packard) and chemoluminescence detection (TEA 502, Thermo Electron).
Artefact control was carried out according to Archer el al. (14) . For sample preservation sodium hydroxide was used. 20 ml of 5 N NaOH solution was added to sample bottles prior to sampling.
Amidopyrine measurements in saliva 1 ml saliva was extracted three times with 2 ml dichloromethane. The combined extracts were dried with sodium sulfate and concentrated to 1 ml. Aliquots of 1 -5 ill were analysed by gas chromatography/mass spectrometry (LKB 9000) using the fragmentographic mode. Conditions were: Column: 1.2 m x 0.64 mm o.d. x 2 mm i.d. deactivated glass, packed with 3% silicone OV17 on Chromosorb WHP 80/100 mesh, flow: 20 ml/min He; the mass spectrometer was focussed on mass 231 to record the parent ion (M + ) of amiodpyrine. Saliva samples for the determination were obtained from different volunteers in an earlier study (volunteers E, B, and S; see Figure 1 ).
Amidopyrine nitrosation assay in saliva
After intake of 500 mg AP and a nitrate-rich vegetable juice (containing 200 mg NOf) saliva samples were collected at time intervals indicated in Figure 2 . Immediately after sampling 2 ml saliva was taken and adjusted to pH 3 using 0.5 N HC1 and incubated for 15 min at 37°C. The reaction was stopped by adding 2 ml 
Results
Amidopyrine in saliva
AP was detected in the saliva of all volunteers after intake of 0.5 g; levels ranged from 3 to 5 /*g/ml during the first 90 min and decreased to ~ 1 -2 /tg/ml after 5 h (Figure 1 ). There were no big differences in AP saliva concentrations between the. individual volunteers after the initial distribution period. Further determinations (not included in Figure 1) showed that AP levels were still above 0.5 ^g/ml for up to 8 h. Nitrite and nitrate in saliva and urine Nitrite levels in saliva ranged from 3 to 20 p.p.m. before the start of the experiment. Only slight increases during the day were observed in experiments (protocol 2) with low nitrate intake. A 3-to 20-fold rise in nitrite concentration could be measured 30 to 180 min after intake of a nitrate-rich vegetable (250 mg NO3). The highest observed nitrite level was 220 p.p.m. (Table I) .
Nitrate levels in saliva ranged from 5 to 75 p.p.m. in the morning and increased to 10 -210 p.p.m. without and to 23 -1130 p.p.m. with nitrate-rich diet, respectively.
In urine no detectable amounts of nitrite could be found. Whereas nitrate concentrations in urine showed great variations, the absolute amount of nitrate excreted per hour did not change very much and could be related to the amount of nitrate ingested during the experiment.
Nitrosation assay of AP in saliva
To demonstrate the extreme ease of NDMA formation from AP a nitrosation assay in saliva was performed. Saliva samples which were collected after intake of 500 mg AP, and a nitrate-rich vegetable juice, were incubated for 15 min at pH 3 and 37 °C, simulating conditions in the stomach. From Figure 2 it can be seen that the NDMA formation starts after 30 min, to reach a maximum of 990 ng/ml after 2.5 h and was not yet finished after 5h.
NDMA excretion in urine
Urine collected before intake of AP did not contain detectable amounts of NDMA (limit of detection 0.05 /*g/l). After 0.5 to 1 h following AP administration NDMA appeared in urine in concentrations ranging from 0.4-1.3/tg/l in cases with a preceeding ethanol intake (see Table I ). Peak concentrations were measured between 1 and 4 h after AP intake; after intake of or at the detection limit. The absolute amounts of NDMA excreted in urine following intake of 0.5 g AP were calculated and are given in Table II for each protocol for volunteers A, B and C.
It should be pointd out that this figure represents only the amounts excreted within the first 5 -6 h.
A typical excretion profile of NDMA (volunteer A, protocol 1) is given in Figure 3 . For comparison nitrite levels in saliva are also presented. ethanol, the maximum NDMA levels were between 0.7 and 15 jtg/1. Intake of a nitrate-rich diet led to higher urinary NDMAlevels in two volunteers (A and B).
High nitrosamine levels were observed in experiments with simultaneous ethanol and AP intake (Protocols 1 and 2). In these cases NDMA was still measurable after 6 h of AP intake so that some NDMA excreted later in this time period remained undetectable. After intake of AP without ethanol the maximum NDMA concentrations in urine ranged between 0.05 and 0.3 figfl. In the absence of AP intake, NDMA concentrations were either below Discussion After intake of the nitrosatable drug AP it was possible to detect NDMA in urine. With the application of ethanol the amounts of detectable NDMA could be increased considerably. This effect could not be observed in control experiments without AP intake. It can therefore be concluded that the excreted NDMA derives from endogenously nitrosated AP. In earlier investigations (8) the effect of ethanol on excretion rate of NDMA was observed after ingestion of the preformed nitrosamine. In these studies the excretion rate of unmetabolized NDMA was 0.5-2.4%. If the influence of ethanol on excretion rate is comparable in both cases, uptake of NDMA formed in vivo and NDMA ingested preformed, the actual amount of NDMA found in urine is only a minor fraction of the total amount formed endogenously. Therefore the total NDMA formed by in vivo nitrosation of 500 mg AP can be assumed to be in the order of 25-1800^.
The relatively long period of NDMA excretion can be explained by the two different in vivo nitrosation conditions which have to be considered, (i) After oral intake of AP there is a very high concentration of the drug in the stomach. Nitrosation, however, is limited at this moment by the low nitrite concentration, (ii) After absorption of AP the drug is excreted by salivary glands for a long period (6 -8 h) in a /ig/ml concentration. Together with nitrite which is formed in the oral cavity from nitrate the drug enters the acidic stomach with a continuous flow for several hours. The decreasing amount of stomach content favours the nitrosation reaction. The total amount of AP secreted by salivary glands can be calculated to be 1-2 mg.
Our data show clearly that in vivo formation of NDMA after intake of a nitrosatable drug occurs in humans. To our knowledge this is the first time that the endogenous formation of a carcinogenic nitrosamine in humans was directly demonstrated. Other studies describe biological monitoring of heterocyclic nitrosamines, such as the tumorigenic (15) mononitrosopiperazine (16) and the non-carcinogenic nitrosoproline (17) to determine endogenous nitrosation in humans.
Under normal conditions a formation of small amounts (10 -500 /ig) of NDMA cannot be observed due to its high metabolic conversion rate. The increased excretion rate which is caused by consumption of ethanol is consistent with previous reports of inhibition of NDMA metabolism in rat liver microsomes (9, 11) . It could also be shown that, in the intact liver perfused with NDMA, it takes very low concentrations of ethanol to suppress NDMA metabolism totally (12) . Due to inhibition of hepatic NDMA metabolism by ethanol more of the carcinogen can reach peripheral tissue, e.g., the kidneys. According to this concept Swann (10) found increased alkylation rates of rat kidney DNA following administration of NDMA with ethanol rather than without.
